AI-Guided First-Line Immunotherapy Selection in Unresectable Hepatocellular Carcinoma
Clinical trial NCT07729618 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07729618
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-12-01
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.